Results

Total Results: 1,939 records

Showing results for "event".

141. Depression in Children: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/childhood-depression/protocol
     August 24, 2018 - depression chronicity (first episode vs. recurrent), comorbid conditions, exposure to a traumatic life event … type, severity), history of previous treatment, comorbid condition, and exposure to a traumatic life event … Abbreviations: AE = adverse event; BDI = Beck Depression Inventory; CAS: The Child Assessment Schedule … of the sample (adolescent vs. younger children), comorbid conditions, exposure to a traumatic life event … SH] OR mortality[SH] OR poisoning[SH] OR toxicity[SH] OR adverse effect*[Title/Abstract] OR adverse event

142. Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-effectiveness/abstract
     February 08, 2011 - procedure indication) as well as propensity scores used as inverse probability weights in the time to event

143. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-risk Preschoolers; Long-term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/adhd/research-protocol
     August 10, 2010 - < 6 years of age with ADHD or Disruptive Behavior Disorder, what are the effectiveness and adverse event … Among people 6 years of age or older with ADHD, what are the effectiveness and adverse event outcomes … Descriptive Statistics Outcomes Numerical or statistical results of any effectiveness or adverse event … outcomes Numerical or statistical results of any effectiveness or adverse event outcomes

144. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - or withdrawal due to any adverse event did not reach statistical significance). … Meloxicam was also associated with decreased risk of any adverse event (RR 0.91, 95% CI 0.84 to 0.99) … Etodolac was associated with lower risk of any adverse event compared to nonselective NSAIDs (RR 0.83 … However, because the event rates increases in older patients, even if the relative risk estimates are … the same, the absolute event rates are higher.

145. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - inhibitors, and considerations for restarting anticoagulation therapy in patients after a hemorrhagic event … therapy or performing a procedural intervention as a stroke prevention strategy following a hemorrhagic event … heart failure, coronary artery disease, and high cholesterol); patients with prior stroke (by type of event … Page 7 o KQ 6: Other strategies for resuming anticoagulation therapy following a hemorrhagic event … failure, coronary artery disease, and high cholesterol) o Patients with prior stroke (by type of event

146. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - 1/00 and 11/30/01; patients who changed medicines were included in both groups Duration to event … in patients taking low-dose aspirin and time-to-event of other GI events including 1) complicated … Cumulative 12-wk incidence of any moderate to severe upper GI AE based on Kaplan-Meier time-to- event … Lumiracoxib compared less favorably with naproxen (0.37% event rate with lumiracoxib v 0.22% event rate … COX-2 vs NSAID: Overall RR of any vascular event among heterogeneous studies 1.0%/yr vs 0.9%/yr was

147. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - stroke (hemorrhagic, ischemic, or unspecified), transient ischemic attack, unspecified cerebrovascular event … cancer, treatment adherence, withdrawal due to adverse events, participants with at least one adverse event … Overall, 5 percent of participants had an event. … Compared with statin monotherapy, more participants developed at least one adverse event with statin-BAS … Nevertheless, all-cause mortality was a rare event across most trials. Followup duration.

148. Draft-Living-Review-Plant-Chronic-Pain-E-Cohort-Studies (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-cohort-studies.xlsx
     March 25, 2024 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … error SF-36 Short-form 36 Question Survey THC tetrahydrocannabinol TRAE treatment related adverse event

149. Comparative Effectiveness of Beta-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/heart-failure-rehospitalization/research
     November 30, 2007 - before the index hospitalization and during followup until being censored or experiencing an outcome event

150. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
     July 01, 2009 - There were 84 studies that reported at least one adverse event associated with RFA. … 0 percent to 5 percent (median 1 percent) of patients in the 70 studies that reported this adverse event … Atrioesophageal fistula was reported in 26 studies: 5 studies reported 1 case each, with event rates … RFA monitoring and use modalities that are more sensitive to asymptomatic recurrences of AF (e.g., event … All studies should actively collect adverse event data from study participants.

151. CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
     May 01, 2021 - and that the findings of the studies did not constitute evidence of increased risk of the adverse event … and that the findings of the studies did not constitute evidence of increased risk of the adverse event … and that the findings of the studies did not constitute evidence of increased risk of the adverse event … when determining whether studies are warranted, including the severity and frequency of the adverse event

152. Draft Report: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/draft-report-plant-based-treatment.pdf
     March 01, 2021 - Understanding how cannabis products’ adverse event profiles compare with other available treatments … Based on two RCTs, incidence of any adverse event was significantly higher in the THC/CBD groups than … Although more patients reported any adverse event while using CBDV than placebo (91% vs. 79%), the … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … Understanding how cannabis products’ adverse event profiles compare with other available treatments

153. Cannabis-App-F5-Table-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2.xlsx
     January 22, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

154. Appendix-E-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5.xlsx
     November 04, 2021 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

155. Cannabis-App-F5-Table-Surveillance-Report-2 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0.xlsx
     February 16, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

156. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
     February 16, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

157. Appendix-E-Table-E5 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
     November 04, 2021 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

158. A total of 1,364 patients were treated with a neurothrombectomy device as part of X reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
     July 01, 2014 - Naming of proxy decisionmaker Preferences for emergency management of acute life threatening event … Preferences for ongoing management of chronic illness in event of loss of decisional capacity, … Role definition for proxy, criteria to consider proxy appropriateness Probability of adverse event … proximity to need for clinical decision Healthy End of life Life threatening Illness or event … Potentially life threatening illness Hospice or frail elderly Life threatening Illness or event

159. Comparative Effectiveness of Physical Therapy for Knee Pain Secondary to Osteoarthritis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/arthritis-knee-physical-therapy/research-protocol
     March 02, 2011 - report the results from random effects models only. 45 The number needed to treat to achieve one event … rate – treatment group event rate). … of avoided or excess events (respectively) per population of 1000 is the difference between the two event … rates multiplied by 1000: (control group event rate – treatment group event rate)*1000. … Visual Analogue Scale WOMAC Western Ontario McMaster Summary of Protocol Amendments In the event

160. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
     August 10, 2010 - < 6 years of age with ADHD or Disruptive Behavior Disorder, what are the effectiveness and adverse event … Among people 6 years of age or older with ADHD, what are the effectiveness and adverse event outcomes … Descriptive Statistics Outcomes  Numerical or statistical results of any effectiveness or adverse event … outcomes  Numerical or statistical results of any effectiveness or adverse event outcomes 